Navigation Links
Warner Chilcott Announces 2009 Financial Guidance
Date:1/27/2009

HAMILTON, BERMUDA, Jan. 27 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today a view of anticipated full year 2009 results.

Total revenues for 2009 are expected to be in the range of $1,015 to $1,025 million, with the results primarily being driven by LOESTRIN 24 FE, DORYX, and TACLONEX. Gross profit margin, as a percentage of total revenues, is anticipated to be in the range of 79% to 80% in 2009.

Total selling, general and administrative (SG&A) expenses in 2009 are anticipated to be in the range of $199 to $208 million. For a detailed view of the components of SG&A please refer to the summary at the end of this press release.

Total R&D spend in 2009 is anticipated to be in the range of $77 to $80 million. Included in this amount is internal R&D expense of $61.5 to $64.5 million and anticipated potential milestone payments to third parties of $15.5 million.

Based on the current view, 2009 GAAP net income is expected to be in the range of $174 to $186 million. Cash net income in 2009 is anticipated to be in the range of $390 to $402 million. Using 251.4 million Class A shares, the Company expects cash net income per share to be in the range of $1.55 to $1.60 for the full year 2009.

References in this press release to "cash net income" mean the Company's net income adjusted for the after-tax effects of two non-cash items: amortization of intangible assets and amortization (or write-off) of deferred loan costs related to the Company's debt. Reconciliations from the Company's anticipated US GAAP results to cash net income expected results are presented in the footnotes at the end of this press release.

For a full view of the Company's 2009 financial guidance please refer to the summary at the end of this press release.<
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Warner Chilcott Announces 2009 Financial Guidance Conference Call
2. Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
3. Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
4. Warner Chilcott to Present at the 27th Annual JP Morgan Healthcare Conference
5. Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment
6. Warner Chilcott to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
7. Warner Chilcott Announces Receipt of Paragraph IV Certification Notices
8. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance
9. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2008 Financial Results
10. House Passes Historic Bill to Protect Kids From Tobacco; Senators Webb & Warner Should Cosponsor Legislation
11. Fitness and Figure Professionals Kirsten Nicewarner and Michelle Adams to Represent GNC at Vails Teva Mountain Games
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 25, 2014 This is a ... of the Galactooligosaccharides (GOS) industry in Global ... of the industry, including definitions, applications and industry ... market analysis are provided with a focus on ... market. A comparison between the international and Chinese ...
(Date:7/25/2014)... 25, 2014 Drexel University College of ... MD, MS, FACP, has been appointed vice dean for education, ... Drexel from The Commonwealth Medical College, where she is currently ... clinical affairs, and professor of medicine. , As a ... College, Weber had a major role in many aspects of ...
(Date:7/25/2014)... News) -- Shift workers, especially men, may be at higher ... such schedules, a new study suggests. Also at special ... schedule, with shifts moving around at various times of the ... one expert, Dr. Alan Manevitz, a clinical psychiatrist at Lenox ... known that working shifts disrupts many key body chemicals, creating ...
(Date:7/25/2014)... FRIDAY, July 25, 2014 (HealthDay --, Treatment for lymphoma ... Hodgkin lymphoma and non-Hodgkin lymphoma, which are cancers of ... who are still in their reproductive years. For men, ... production. Although most men regain their fertility within two ... be counseled about the possibility of this significant side ...
(Date:7/25/2014)... new system that sent patients to designated cardiac receiving ... sudden cardiac arrest in Arizona, according to a study ... Medicine . , "We knew lives would be ... guidelines for post-cardiac arrest care and we were able ... to what is done for Level 1 trauma patients," ...
Breaking Medicine News(10 mins):Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 2Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 3Health News:Study Links Shift Work to Risk for Type 2 Diabetes 2Health News:Study Links Shift Work to Risk for Type 2 Diabetes 3Health News:Lymphoma Treatment May Harm, Halt Men's Sperm Production 2Health News:New EMS system in Arizona dramatically improves survival from cardiac arrest 2Health News:New EMS system in Arizona dramatically improves survival from cardiac arrest 3
... A Georgetown University Medical Center (GUMC) scientist who ... frogs and in the dogfish shark has now turned ... dolphins. A dolphin,s ability to heal quickly from ... to infection, hemorrhage protection, and near-restoration of normal body ...
... and Society of Breast Imaging applaud and support updated ... women begin getting annual mammograms at age 40. The ... American Cancer Society, ACR, Society of Breast Imaging (SBI), ... major medical associations with demonstrated expertise in breast cancer ...
... Reporter , WEDNESDAY, July 20 (HealthDay News) -- High-tech helmets ... the force of impact, offering new insight into head and ... help manufacturers design helmets that are more protective, said Steven ... Michigan and lead author of a new report about the ...
... test to distinguish harmless from precancerous pancreatic cysts. ... surgery to remove the harmless variety. A report ... issue of Science Translational Medicine . The ... than a million patients each year, most of whom ...
... News) --, Liars can control certain facial expressions when facing ... a new study shows. The researchers noted the findings ... the study, scientists randomly asked 60 people to either lie ... of movie tickets from an envelope. While being interviewed, the ...
... researchers have developed a new strategy to improve the development ... are created by introducing four defined genes to an adult ... cell, which can differentiate into many different types of the ... Oct4, Sox2, Klf4 and c-Myc, a combination known as OSKM. ...
Cached Medicine News:Health News:Dolphins' 'remarkable' recovery from injury offers important insights for human healing 2Health News:Dolphins' 'remarkable' recovery from injury offers important insights for human healing 3Health News:ACR, SBI support updated ACOG recommendations that women begin annual mammograms at age 40 2Health News:High-Tech Football Helmets Gauge Force of Collision 2Health News:Benign or cancerous? Gene test predicts cancer potential in pancreatic cysts 2Health News:Benign or cancerous? Gene test predicts cancer potential in pancreatic cysts 3Health News:Scrutinizing Faces Might Catch Liars, Study Finds 2Health News:U of M researchers improve method to create induced pluripotent stem cells 2
(Date:7/25/2014)... 25, 2014 /PRNewswire-iReach/ -- Dr. Michael Gabriel of ... reacts to a recent study, which shows how grief in ... http://photos.prnewswire.com/prnh/20140723/129709 According to US ... are more likely than others to grow up overweight or ... There were two specific types of stress that caused ...
(Date:7/24/2014)...  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... conference call to report its second quarter 2014 financial ... and outlook on Thursday, August 7, 2014 at 8:30 ... The call can be accessed by dialing ... prior to the start of the call and providing ...
(Date:7/24/2014)... , Germany , and ... -- , Exclusive global license ... for SF3B1 mutations, including next-generation sequencing (NGS) gene panels, ... to be targeted by new test, indicate favorable prognosis ... syndromes  QIAGEN sees potential for developing companion ...
Breaking Medicine Technology:Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5
... Dec. 5, 2010 Pfizer Inc. (NYSE: ... has elected Ian C. Read, 57, currently head of ... Officer and Director. Mr. Read succeeds Jeffrey B. Kindler, ... (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) The Board,s Lead Independent Director, ...
... The Infectious Disease Research Institute (IDRI) has ... Advance Research and Development Authority (BARDA). IDRI,s work will ... to $8.5 million over three years when further development ... agency. "BARDA is supporting an important ...
Cached Medicine Technology:Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer 2Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer 3Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer 4IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza 2
Aplio was designed for intuitive operation so you can get the results you are looking for quickly and easily. From customizable measurement packages to an ergonomic platform design, Aplio was built m...
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Fludeoxyglucose F 18 Injection:, The PETNET SafetyNET: 99% On-Time Delivery of MetaTrace FDG , Largest Cyclotron - Equipped Radiopharmacy Network , 39 MetaTrace FDG producing sites , Customi...
... The AB Holter, a ... system, provides sophisticated,ambulatory ECG analysis ... Windows environment.,Designed to use Windows ... the system allows,the option of ...
Medicine Products: